HSPC

Hematopoietic stem and progenitor cells (HSPCs) are stem cells characterized by their ability to grow new blood cells, a process known as hematopoiesis. Hematopoiesis occurs in the bone marrow in the center of most bones in the adult human body. HSPCs give rise to various types of immune cells, including myeloid and lymphoid lineages.

What's Popular in HSPC

Trending News

MAR 05, 2021

Cancer

Can bone marrow recover post-chemotherapy?

New research stemming from Osaka University reports identifying the mechanism by which hematopoietic stem and progenitor ...

Written By: Kathryn DeMuth Sullivan

2

MAR 05, 2020

Drug Discovery & Development

Human Stem Cells Cure Type 1 Diabetes in Mice

In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and ...

Written By: Annie Lennon

3

MAR 05, 2021

Cancer

Can bone marrow recover post-chemotherapy?

New research stemming from Osaka University reports identifying the mechanism by which hematopoietic stem and progenitor ...

Written By: Kathryn DeMuth Sullivan

MAR 05, 2020

Drug Discovery & Development

Human Stem Cells Cure Type 1 Diabetes in Mice

In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and ...

Written By: Annie Lennon

Webinars

JUL 22, 2021 | 12:45 PM

An Engineered AsCas12a nuclease facilitates the rapid generation...

Though AsCas12a fills a crucial gap in the current genome editing toolbox, it exhibits relatively poor editing efficiency, restricting its overall utility. In collaboration with Integrated D...

Speaker: John Zuris, PhD

Presented at: GenScript Gene & Cell Engineering Virtual Summit

3

APR 20, 2020 | 9:00 AM

Hematopoietic Cell Therapy Products: Determining Potency and Stability

DATE: April 20, 2020 TIME: 9:00am PT, 12:00pm ET...

Speaker: Jackie Damen, PhD

Sponsored By: STEMCELL Technologies

13 1

JUL 22, 2021 | 12:45 PM

An Engineered AsCas12a nuclease facilitates the rapid generation...

Though AsCas12a fills a crucial gap in the current genome editing toolbox, it exhibits relatively poor editing efficiency, restricting its overall utility. In collaboration with Integrated D...

Speaker: John Zuris, PhD

Presented at: GenScript Gene & Cell Engineering Virtual Summit

APR 20, 2020 | 9:00 AM

Hematopoietic Cell Therapy Products: Determining Potency and Stability

DATE: April 20, 2020 TIME: 9:00am PT, 12:00pm ET...

Speaker: Jackie Damen, PhD

Sponsored By: STEMCELL Technologies

13 1

Virtual Events

JUL 22, 2021 | 5:00 AM PDT

GenScript Gene & Cell Engineering Virtual Summit

Gene and cell engineering advances have influenced almost all branches of life sciences. From the lab to the clinic, innovative gene synthesis technologies and gene editing tools have transf...

42

JUL 22, 2021 | 5:00 AM PDT

GenScript Gene & Cell Engineering Virtual Summit

Gene and cell engineering advances have influenced almost all branches of life sciences. From the lab to the clinic, innovative gene synthesis technologies and gene editing tools have transf...